Logo image of OTRK

ONTRAK INC (OTRK) Stock Fundamental Analysis

NASDAQ:OTRK - Nasdaq - US6833734014 - Common Stock - Currency: USD

1.592  -0.07 (-4.1%)

After market: 1.531 -0.06 (-3.83%)

Fundamental Rating

2

OTRK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 108 industry peers in the Health Care Providers & Services industry. OTRK has a bad profitability rating. Also its financial health evaluation is rather negative. OTRK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OTRK had negative earnings in the past year.
OTRK had a negative operating cash flow in the past year.
OTRK had negative earnings in each of the past 5 years.
In the past 5 years OTRK always reported negative operating cash flow.
OTRK Yearly Net Income VS EBIT VS OCF VS FCFOTRK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

OTRK has a worse Return On Assets (-159.29%) than 95.33% of its industry peers.
OTRK has a worse Return On Equity (-311.45%) than 85.05% of its industry peers.
Industry RankSector Rank
ROA -159.29%
ROE -311.45%
ROIC N/A
ROA(3y)-156.54%
ROA(5y)-118.81%
ROE(3y)-473.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OTRK Yearly ROA, ROE, ROICOTRK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 -1K -1.5K

1.3 Margins

OTRK has a better Gross Margin (64.00%) than 85.05% of its industry peers.
In the last couple of years the Gross Margin of OTRK has grown nicely.
The Profit Margin and Operating Margin are not available for OTRK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.4%
GM growth 5Y20.89%
OTRK Yearly Profit, Operating, Gross MarginsOTRK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

3

2. Health

2.1 Basic Checks

OTRK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OTRK has been reduced compared to 1 year ago.
Compared to 5 years ago, OTRK has less shares outstanding
OTRK has a better debt/assets ratio than last year.
OTRK Yearly Shares OutstandingOTRK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
OTRK Yearly Total Debt VS Total AssetsOTRK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

Based on the Altman-Z score of -32.44, we must say that OTRK is in the distress zone and has some risk of bankruptcy.
OTRK has a Altman-Z score of -32.44. This is amonst the worse of the industry: OTRK underperforms 92.52% of its industry peers.
OTRK has a Debt/Equity ratio of 0.69. This is a neutral value indicating OTRK is somewhat dependend on debt financing.
OTRK has a Debt to Equity ratio of 0.69. This is comparable to the rest of the industry: OTRK outperforms 51.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z -32.44
ROIC/WACCN/A
WACC6.53%
OTRK Yearly LT Debt VS Equity VS FCFOTRK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.17 indicates that OTRK should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.17, OTRK is doing worse than 68.22% of the companies in the same industry.
OTRK has a Quick Ratio of 1.17. This is a normal value and indicates that OTRK is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of OTRK (1.17) is worse than 60.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
OTRK Yearly Current Assets VS Current LiabilitesOTRK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

OTRK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.02%.
The Revenue has decreased by -4.06% in the past year.
OTRK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.44% yearly.
EPS 1Y (TTM)-26.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.94%
Revenue 1Y (TTM)-4.06%
Revenue growth 3Y-46.42%
Revenue growth 5Y-3.44%
Sales Q2Q%-30.94%

3.2 Future

Based on estimates for the next years, OTRK will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.91% on average per year.
Based on estimates for the next years, OTRK will show a very strong growth in Revenue. The Revenue will grow by 45.13% on average per year.
EPS Next Y86.79%
EPS Next 2Y38.89%
EPS Next 3Y24.94%
EPS Next 5Y14.91%
Revenue Next Year-18.59%
Revenue Next 2Y9.8%
Revenue Next 3Y23.24%
Revenue Next 5Y45.13%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OTRK Yearly Revenue VS EstimatesOTRK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
OTRK Yearly EPS VS EstimatesOTRK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OTRK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OTRK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OTRK Price Earnings VS Forward Price EarningsOTRK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OTRK Per share dataOTRK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8 -10

4.3 Compensation for Growth

OTRK's earnings are expected to grow with 24.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.89%
EPS Next 3Y24.94%

More info and screens

0

5. Dividend

5.1 Amount

OTRK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ONTRAK INC

NASDAQ:OTRK (2/21/2025, 8:00:02 PM)

After market: 1.531 -0.06 (-3.83%)

1.592

-0.07 (-4.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)04-14 2025-04-14/amc
Inst Owners15.07%
Inst Owner Change-99%
Ins Owners0.03%
Ins Owner Change0%
Market Cap6.72M
Analysts82.86
Price Target4.08 (156.28%)
Short Float %2.5%
Short Ratio1.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-48.76%
Min EPS beat(2)-86.27%
Max EPS beat(2)-11.24%
EPS beat(4)1
Avg EPS beat(4)-22.41%
Min EPS beat(4)-86.27%
Max EPS beat(4)43.24%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.35%
Min Revenue beat(2)-7.58%
Max Revenue beat(2)-3.13%
Revenue beat(4)0
Avg Revenue beat(4)-6.86%
Min Revenue beat(4)-14.06%
Max Revenue beat(4)-2.69%
Revenue beat(8)0
Avg Revenue beat(8)-27.31%
Revenue beat(12)1
Avg Revenue beat(12)-21.31%
Revenue beat(16)4
Avg Revenue beat(16)-13.37%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.26%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF N/A
P/B 0.59
P/tB 1.17
EV/EBITDA N/A
EPS(TTM)-10.62
EYN/A
EPS(NY)-4.13
Fwd EYN/A
FCF(TTM)-3.07
FCFYN/A
OCF(TTM)-3.02
OCFYN/A
SpS2.66
BVpS2.71
TBVpS1.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -159.29%
ROE -311.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64%
FCFM N/A
ROA(3y)-156.54%
ROA(5y)-118.81%
ROE(3y)-473.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.4%
GM growth 5Y20.89%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.06%
Cap/Sales 1.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z -32.44
F-Score4
WACC6.53%
ROIC/WACCN/A
Cap/Depr(3y)46.16%
Cap/Depr(5y)46.03%
Cap/Sales(3y)5.19%
Cap/Sales(5y)3.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.94%
EPS Next Y86.79%
EPS Next 2Y38.89%
EPS Next 3Y24.94%
EPS Next 5Y14.91%
Revenue 1Y (TTM)-4.06%
Revenue growth 3Y-46.42%
Revenue growth 5Y-3.44%
Sales Q2Q%-30.94%
Revenue Next Year-18.59%
Revenue Next 2Y9.8%
Revenue Next 3Y23.24%
Revenue Next 5Y45.13%
EBIT growth 1Y21.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y23.57%
EBIT Next 5Y22.03%
FCF growth 1Y66.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.04%
OCF growth 3YN/A
OCF growth 5YN/A